Fineline Cube

Follow:
14409 Articles
CompanyDrug

LianBio Completes Enrollment for Mavacamten Phase III Trial in oHCM

CompanyDeals

Huadong Medicine to Acquire 60% Stake in Wuhu Huaren for RMB 396 Million

CompanyDrug

Recbio Completes Enrollment for HPV Vaccine REC603 Immuno-Bridging Study

CompanyDeals

Everest Medicines’ Xerava NDA Accepted by Taiwan’s TFDA

Company

China Grand Pharma’s H1 2022 Revenues Up 14.1% to USD664m, R&D Spending Rises

CompanyDrug

HutchMed and AstraZeneca’s Tagrisso-Orpathys Combo Shows Promise in NSCLC Study

CompanyDrug

NMPA Accepts Roche’s Crovalimab Filing for PNH Treatment with Priority Review

CompanyDrug

Kintor Pharma Completes GT20029 Phase I Study for Hair Loss and Acne

CompanyPolicy / Regulatory

NHSA Cracks Down on Price Gouging in Basic Medical Insurance Scheme

Company

FibroGen’s Roxadustat Sales in China Rise Despite Price Cut

CompanyDrug

Inmagene and HutchMed Dose First Subject in IMG-004 Phase I Study

Company

Zai Lab’s Q2 2022 Financials Show Revenue Growth and R&D Cost Cut